急性视网膜坏死后继发视网膜脱离率及不同干预疗效的系统综述与荟萃分析
该系统综述与荟萃分析纳入67项研究共1811例患者,评估急性视网膜坏死(ARN)后视网膜脱离(RD)的发生率及不同干预措施的疗效。池化结果显示ARN总体RD率为47%,全身抗病毒治疗可显著降低RD率(67%降至43%),预防性玻璃体切除术可显著降低RD率(45%降至22%),但预防性玻璃体切除术可能显著增加增殖性玻璃体视网膜病变发生率(7%升至32%)。
要点
- ARN总体RD率为47%,约半数患眼在病程中可能发生RD。
- 全身抗病毒治疗联合玻璃体切除术的RD率最低,为18%。
- 预防性玻璃体切除术可能显著增加增殖性玻璃体视网膜病变发生率(7%升至32%)。
核心结论
- 约半数ARN患眼在整个病程中可能发生RD。
- 全身抗病毒治疗和预防性玻璃体切除术是预防RD的有效干预措施。
- 预防性激光或辅助性玻璃体腔抗病毒治疗的作用仍不明确。
- 水痘-带状疱疹病毒ARN和广泛视网膜炎病例可能需要强化干预。
研究设计与样本
- 系统综述与荟萃分析,检索Medline和EMBASE数据库自建库至2020年3月。
- 最终纳入67项研究,共1811例患者。
- 使用R软件3.6.3进行统计分析,采用广义线性混合模型计算比例及95%置信区间。
主要发现
- ARN总体RD率为47%。
- RD率随视网膜炎范围增加而升高,累及III区时略低。
- 单纯疱疹病毒ARN的RD率为37%,水痘-带状疱疹病毒ARN为46%。
- 免疫功能正常患者RD率为52%,免疫功能受损患者为39%。
- 首次就诊时2%的患眼已出现RD。
关键数值与推荐
- 全身抗病毒治疗可显著降低RD率,从67%降至43%。
- 预防性玻璃体切除术可显著降低RD率,从45%降至22%。
- 全身抗病毒治疗联合玻璃体切除术的RD率最低,为18%。
- 预防性玻璃体切除术可能显著增加增殖性玻璃体视网膜病变发生率,从7%升至32%。
- 预防性激光或玻璃体腔抗病毒治疗的疗效仍有限。
临床怎么用
- 对ARN患者应考虑全身抗病毒治疗以降低RD风险。
- 预防性玻璃体切除术可降低RD率,但需权衡增殖性玻璃体视网膜病变风险增加。
- 水痘-带状疱疹病毒ARN和广泛视网膜炎病例可能需要更积极的干预。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To estimate the rate of retinal detachment (RD) after acute retinal necrosis (ARN) and evaluate the efficacies of different interventions. METHODS: The databases Medline and EMBASE from inception to March 2020 were searched to identify the relevant studies. R software version 3.6.3 was used to perform the statistical analyses. Results in proportion with 95% confidence interval were calculated using generalized linear mixed models. RESULTS: Sixty-seven studies involving 1,811 patients were finally included. The pooling results suggested the general RD rate of ARN was 47%. The RD rate increased with the extent of retinitis and was slightly lower when involved Zone III. The RD rate was 37% for herpes simplex virus ARN and 46% for varicella-zoster virus ARN; 52% for immunocompetent patients and 39% for immunocompromised patients. Retinal detachment presented in 2% of eyes at the first visit. Systemic antiviral therapy could lower the RD rate significantly from 67% to 43%, and prophylactic vitrectomy could lower the RD rate significantly from 45% to 22%. Systemic antiviral therapy plus vitrectomy achieved the lowest RD rate to 18%. Although the efficacy of prophylactic laser or intravitreal antiviral therapy was still limited. Prophylactic vitrectomy might significantly increase the incidence of proliferative vitreoretinopathy from 7% to 32%. CONCLUSION: About half of the eyes might develop RD during the entire course of ARN. Systemic antiviral therapy and prophylactic vitrectomy are effective interventions to prevent RD, whereas the roles of prophylactic laser or adjunctive intravitreal antiviral therapy are still unclear. Varicella-zoster virus ARN and cases with extensive retinitis might need intensified interventions.
引用
- Zhao XY, Meng LH, Zhang WF, et al. RETINAL DETACHMENT AFTER ACUTE RETINAL NECROSIS AND THE EFFICACIES OF DIFFERENT INTERVENTIONS: A Systematic Review and Metaanalysis. Retina. 2021. PMID: 32932382. doi:10.1097/IAE.0000000000002971
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。